文献速递心力衰竭与心肌病心律失常

心力衰竭住院至一级预防ICD植入时间与患者结局的关系

Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes?
PubMed 文献 · Circulation · 2018-01-01

该研究对医保ICD注册数据中81 180例因一级预防首次植入ICD且射血分数≤35%的心衰患者进行事后分析,按距最近心衰住院时间分组。当前或近期心衰住院者围术期并发症更高,当前住院者90天死亡风险增加。

要点

  • 当前心衰住院时植入ICD者90天死亡风险为对照的2.25倍(95%CI 2.02-2.52)。
  • 当前或近期心衰住院者围术期并发症率高于无近期住院者。
  • 当前心衰住院与90天全因再入院风险升高相关(OR 1.89)。

核心结论

  • 当前或近期因心衰住院的老年患者首次植入一级预防ICD时围术期并发症率更高,且当前住院者90天死亡风险增加。
  • 需开展前瞻性、真实世界、务实的比较效果研究以明确ICD植入的最佳时机。

研究设计与样本

  • 对参加国家心血管数据注册ICD注册的医保受益人进行事后分析。
  • 纳入已知心衰诊断且射血分数≤35%、因一级预防首次植入ICD的患者,最终分析队列81 180例。
  • 按距最近心衰住院时间分组:当前住院(n=11 563,14%)、3个月内住院(n=6252,8%)、>3个月或无心衰住院(n=63 365,78%)。
  • 采用多变量logistic回归模型评估ICD植入时机与结局的关联。

主要发现

  • 当前或近期心衰住院者未调整围术期并发症复合率为2.60% vs 1.71% vs 1.25%(P<0.001)。
  • 调整潜在混杂因素后,当前心衰住院者90天死亡风险更高(OR 2.25;95%CI 2.02-2.52;P<0.001)。
  • 当前心衰住院者90天全因再入院风险更高(OR 1.89;95%CI 1.79-1.99;P<0.001)。

临床怎么用

  • 对当前或近期心衰住院的老年患者,植入一级预防ICD前应充分评估围术期并发症与死亡风险。
  • ICD植入时机需个体化权衡,避免在心衰住院急性期常规植入。

局限性

  • 本研究为事后分析,可能存在残余混杂。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Landmark studies have demonstrated the safety and efficacy of implantable cardioverter-defibrillators (ICDs) in selected stable ambulatory patients with heart failure (HF) with a reduced ejection fraction receiving optimal medical therapy. It is not known whether a recent hospitalization for HF before ICD placement is associated with subsequent outcomes. METHODS: A post hoc analysis was performed of Medicare beneficiaries enrolled in the National Cardiovascular Data Registry's ICD Registry with a known diagnosis of HF and an ejection fraction ≤35% underdoing a new ICD placement for primary prevention. Patients were grouped based on the timing of ICD placement from the last hospitalization for HF. The association between timing of ICD placement and outcomes was assessed by using multivariable logistic regression models. RESULTS: The final analytic cohort included 81 180 patients undergoing initial ICD placement for primary prevention who were currently hospitalized for HF (n=11 563, 14%), hospitalized for HF within 3 months (n=6252, 8%), or hospitalized for HF >3 months previously or had no previous hospitalizations for HF (n=63 365, 78%). Patients currently or recently hospitalized for HF had a higher unadjusted composite periprocedural complication rate (2.60% versus 1.71% versus 1.25%, P<0.001). After adjusting for potential confounders, patients currently hospitalized for HF were at higher risk for death (odds ratio, 2.25; 95% CI, 2.02-2.52; P <0.001) and all-cause readmission (odds ratio, 1.89; 95% CI, 1.79-1.99; P <0.001) at 90 days. CONCLUSION: Older patients currently or recently hospitalized for HF undergoing initial ICD placement for primary prevention experienced a higher rate of periprocedural complications and were at increased risk of death in comparison with those receiving an ICD without recent HF hospitalization. Additional prospective, real-world, pragmatic, comparative effectiveness studies should be conducted to define the optimal timing of ICD placement.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Ambrosy AP, Parzynski CS, Friedman DJ, et al. Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes? Circulation. 2018. PMID: 30565983. doi:10.1161/CIRCULATIONAHA.118.035627

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。